SIMULPHARMA ApS — Credit Rating and Financial Key Figures

SIMULPHARMA ApS (CVR number: 32832075) is a company from RUDERSDAL. The company reported a net sales of 0.2 mDKK in 2024, demonstrating a growth of 38.2 % compared to the previous year. The operating profit percentage was at 25.9 % (EBIT: 0 mDKK), while net earnings were 41.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 83.5 %, which can be considered excellent and Return on Equity (ROE) was 95.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 83.5 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. SIMULPHARMA ApS's liquidity measured by quick ratio was 6.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.